These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21397628)
1. Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Birkett MA; Shinday NM; Kessler EJ; Meyer JS; Ritchie S; Rowlett JK Pharmacol Biochem Behav; 2011 Jun; 98(4):544-51. PubMed ID: 21397628 [TBL] [Abstract][Full Text] [Related]
2. Lithium potentiated, pyridoxine abolished and fluoxetine attenuated the anxiolytic effect of diazepam in mice. Walia V; Garg C; Garg M Brain Res Bull; 2019 Aug; 150():343-353. PubMed ID: 31201833 [TBL] [Abstract][Full Text] [Related]
3. Selective corticotropin-releasing factor 1 receptor antagonist E2508 has potent antidepressant-like and anxiolytic-like properties in rodent models. Taguchi R; Shikata K; Furuya Y; Ino M; Shin K; Shibata H Behav Brain Res; 2016 Oct; 312():138-47. PubMed ID: 27297028 [TBL] [Abstract][Full Text] [Related]
4. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. Da-Rocha MA; Puech AJ; Thiébot MH J Psychopharmacol; 1997; 11(3):211-8. PubMed ID: 9305412 [TBL] [Abstract][Full Text] [Related]
5. Reproductive experience alters the effects of diazepam and fluoxetine on anxiety-like behaviour, fear extinction, and corticosterone levels in female rats. Pestana JE; Graham BM Psychopharmacology (Berl); 2023 Dec; 240(12):2515-2528. PubMed ID: 37581635 [TBL] [Abstract][Full Text] [Related]
6. Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice. Takeuchi T; Owa T; Nishino T; Kamei C Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):113-21. PubMed ID: 20401348 [TBL] [Abstract][Full Text] [Related]
7. The role of hippocampal GABA Farajdokht F; Vosoughi A; Ziaee M; Araj-Khodaei M; Mahmoudi J; Sadigh-Eteghad S Mol Biol Rep; 2020 Sep; 47(9):6487-6496. PubMed ID: 32778988 [TBL] [Abstract][Full Text] [Related]
8. Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action. Fitzpatrick CM; Larsen M; Madsen LH; Caballero-Puntiverio M; Pickering DS; Clausen RP; Andreasen JT Behav Pharmacol; 2016 Sep; 27(6):549-55. PubMed ID: 27341500 [TBL] [Abstract][Full Text] [Related]
9. An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice. Belzung C; Le Guisquet AM; Barreau S; Calatayud F Behav Pharmacol; 2001 Jun; 12(3):151-62. PubMed ID: 11485052 [TBL] [Abstract][Full Text] [Related]
10. Behavioral and neurochemical changes following predatory stress in mice. Belzung C; El Hage W; Moindrot N; Griebel G Neuropharmacology; 2001 Sep; 41(3):400-8. PubMed ID: 11522332 [TBL] [Abstract][Full Text] [Related]
11. The effects of the co-administration of the α₁-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat. Takamura N; Masuda T; Inoue T; Nakagawa S; Koyama T Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):107-11. PubMed ID: 22658980 [TBL] [Abstract][Full Text] [Related]
12. Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models. Maximino C; Puty B; Benzecry R; Araújo J; Lima MG; de Jesus Oliveira Batista E; Renata de Matos Oliveira K; Crespo-Lopez ME; Herculano AM Neuropharmacology; 2013 Aug; 71():83-97. PubMed ID: 23541719 [TBL] [Abstract][Full Text] [Related]
13. Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice? Koek W; Mitchell NC; Daws LC Behav Pharmacol; 2018 Jun; 29(4):365-369. PubMed ID: 29035921 [TBL] [Abstract][Full Text] [Related]
14. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization. Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239 [TBL] [Abstract][Full Text] [Related]
15. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats. Durand M; Berton O; Aguerre S; Edno L; Combourieu I; Mormède P; Chaouloff F Neuropharmacology; 1999 Jun; 38(6):893-907. PubMed ID: 10465693 [TBL] [Abstract][Full Text] [Related]
16. Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise. Greenwood BN; Strong PV; Brooks L; Fleshner M Psychopharmacology (Berl); 2008 Aug; 199(2):209-22. PubMed ID: 18454279 [TBL] [Abstract][Full Text] [Related]
17. Effects of chronic fluoxetine treatment on anxious behaviour of BALB/c mice in a 3-dimensional maze. Abuhamdah RM; Hussain MD; Chazot PL; Ennaceur A Stress; 2015; 18(6):677-85. PubMed ID: 26365460 [TBL] [Abstract][Full Text] [Related]
18. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Griebel G; Belzung C; Perrault G; Sanger DJ Psychopharmacology (Berl); 2000 Feb; 148(2):164-70. PubMed ID: 10663431 [TBL] [Abstract][Full Text] [Related]
19. Chronic mild stress-induced changes of risk assessment behaviors in mice are prevented by chronic treatment with fluoxetine but not diazepam. Wang C; Li M; Sawmiller D; Fan Y; Ma Y; Tan J; Ren Y; Li S Pharmacol Biochem Behav; 2014 Jan; 116():116-28. PubMed ID: 24291732 [TBL] [Abstract][Full Text] [Related]
20. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Kamei J; Miyata S; Morita K; Saitoh A; Takeda H Pharmacol Biochem Behav; 2003 May; 75(2):247-54. PubMed ID: 12873612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]